CSCPDTtrial
Not Applicable
- Conditions
- central serous chorioretinopathyH357
- Registration Number
- JPRN-jRCTs051180224
- Lead Sponsor
- Sotozono Chie
- Brief Summary
8 eyes were enrolled in this study. PDT for CSC seemed to be a short-term efficacy and safety profile in this study. Because this study was unexpectedly conducted in a small number of cases, we are unable to conclude the efficacy and safety of PDT for CSC.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
1.3 months or more after onset
2.presence of active angiographic leakage under or adjacent to fovea
in fluorescein angiography
3.presence of serous retinal detachment on optical coherence tomography
4.written informed consent
Exclusion Criteria
1. drug allery to verteporfin
2. pregnant or expecting pregnancy
3. porphyria
4. macular diseases other than central serous chorioretinopathy
5. others (inappropriate case judged by investigator or subinvestigators)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method